SUSAN WOSIK: Open Payments
NPI 1104379601 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 8 payments from 6 companies in 2025. Trend: 2023 $839 · 2024 $2,831 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Madrigal Pharmaceuticals | 1 | $117 |
| ABBVIE INC. | 3 | $77 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| CORDIS US CORP. | 1 | $21 |
Products named: ENTYVIO, REZDIFFRA, MAVYRET, JOURNAVX, IQIRVO, MYNX CONTROL VENOUS, RINVOQ.
Industry payments across MI — which companies pay providers there.
